EU trade group advises on clinical trial conduct during COVID-19

The leading trade group representing the European pharma industry has released guidance on managing clinical trials under the changing circumstances brought about by the COVID-19 pandemic.

Agencies in Europe, including the European Medicines Agency, have published guidance  for sponsors on clinical trial conduct during the pandemic.

In the USA, the Food and Drug Administration has also  issued guidance for drugmakers, investigators and others developing options targeting the SARS-CoV-2 virus.